Ingrid Ortiz
Family · Hampton, VANPI 1225669138
Payments from drug & device makers
Across 332 payments — averaging $28.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$2K
- Astellas Pharma US Inc$2K
- Sumitomo Pharma America, Inc.$1K
- AbbVie$576
- Pfizer$533
- Coloplast$402
- plus $3K from 30 others
What the payments were for
- Travel & lodging$1,16912%
- Food & beverage$7,68582%
- Education$5416%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 17 | $1,582 |
| Astellas Pharma US Inc | 49 | $1,551 |
| Sumitomo Pharma America, Inc. | 58 | $1,319 |
| AbbVie | 26 | $576 |
| Pfizer | 22 | $533 |
| Coloplast | 28 | $402 |
| Bayer | 17 | $380 |
| Endo USA, Inc. | 13 | $367 |
| Progenics Pharmaceuticals, Inc. | 9 | $266 |
| Antares Pharma, Inc. | 8 | $231 |
| Merck | 9 | $209 |
| Urovant Sciences Inc | 5 | $199 |
| Blue Earth Diagnostics | 11 | $197 |
| Urogen Pharma, Inc. | 7 | $189 |
| Endo Pharmaceuticals Inc. | 8 | $147 |
| Clarus Therapeutics Inc. | 3 | $143 |
| Accord Healthcare, Inc. | 7 | $131 |
| E.r. Squibb & Sons, L.L.C. | 1 | $119 |
| Procept Biorobotics Corporation | 2 | $106 |
| C. R. Bard, Inc. & Subsidiaries | 4 | $86 |
| Johnson & Johnson | 3 | $76 |
| 180 Medical, Inc. | 1 | $65 |
| Alnylam Pharmaceuticals Inc. | 1 | $58 |
| Boston Scientific | 2 | $56 |
| Teleflex LLC | 2 | $52 |
| Immunitybio, Inc. | 3 | $51 |
| Novartis | 2 | $49 |
| Myriad Genetic Laboratories, Inc. | 3 | $47 |
| Azurity Pharmaceuticals, Inc. | 2 | $40 |
| Ambu Inc. | 2 | $40 |
| Novo Nordisk | 2 | $38 |
| Telix Pharmaceuticals | 1 | $20 |
| ABC Home Medical Supply, Inc. | 1 | $20 |
| Tolmar, Inc. | 1 | $19 |
| Innovation Technologies Inc | 1 | $15 |
| Hollister Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,395 in reported general payments places this provider in the 95th percentile of 4,332 family providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 93 | $80,768 |
| GemtesaVibegron | 40 | $41,835 |
| Testosterone | 25 | $7,471 |
| Testosterone Cypionate | 92 | $6,555 |
| Tamsulosin Hcl | 224 | $2,556 |
| Tolterodine Tartrate ErTolterodine Tartrate | 11 | $2,065 |
| Potassium Citrate ErPotassium Citrate | 15 | $1,248 |
| Estradiol | 21 | $1,195 |
| NitrofurantoinNitrofurantoin Macrocrystal | 44 | $969 |
| Cephalexin | 65 | $961 |
| Solifenacin Succinate | 19 | $799 |
| Finasteride | 85 | $726 |
| Dutasteride | 13 | $620 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $499 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 38 | $360 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $1,551 | $80,76893 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $1,319 | $41,83540 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,332 family providers in Virginia.
Other family in Hampton
- Adam MedlinHampton$67K
- Ashley ForemanHampton$18K
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Casey SharpDanville$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.